Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Cann American Corp

Healthcare US CNNA

0.003USD
0.0006(25.00%)

Last update at 2026-06-18T13:30:00Z

Day Range

0.0020.0069
LowHigh

52 Week Range

0.00010.004
LowHigh

Fundamentals

  • Previous Close 0.0024
  • Market Cap0.39M
  • Volume3010200
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-0.27598M
  • Revenue TTM0.01M
  • Revenue Per Share TTM-
  • Gross Profit TTM 0.02M
  • Diluted EPS TTM-4.66

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-02-28 2022-02-28 2020-02-29 2019-02-28 2018-02-28
Type yearly yearly yearly yearly yearly
Date 2023-02-28 2022-02-28 2020-02-29 2019-02-28 2018-02-28
Income before tax - - - -0.00749M -0.00050M
Minority interest - - - - -
Net income - - - -0.00749M -0.00050M
Selling general administrative - - - 0.09M 0.02M
Selling and marketing expenses - - - - -
Gross profit - - - 0.09M 0.02M
Reconciled depreciation - - - - -
Ebit -0.14594M -0.19876M -0.01408M -0.00749M -0.00050M
Ebitda - - - - -
Depreciation and amortization - - - - -
Non operating income net other - - - - -
Operating income - - - -0.00749M -0.00050M
Other operating expenses - - - - -
Interest expense - - 0.00000M 0.00000M 0.00000M
Tax provision - - - - -
Interest income - - - - -
Net interest income - - - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - - - -
Total revenue - - - 0.12M 0.03M
Total operating expenses - - - 0.12M 0.03M
Cost of revenue - - - 0.03M 0.00553M
Total other income expense net - - - - -
Discontinued operations - - - - -
Net income from continuing ops - - - -0.00749M -0.00050M
Net income applicable to common shares 3.82M 10.54M -0.24982M -0.00749M -0.00050M
Preferred stock and other adjustments - - - - -
Breakdown 2023-02-28 2022-02-28 2020-02-29 2019-02-28 2018-02-28
Type yearly yearly yearly yearly yearly
Date 2023-02-28 2022-02-28 2020-02-29 2019-02-28 2018-02-28
Total assets - - - 0.19M 0.20M
Intangible assets - - - - -
Earning assets - - - - -
Other current assets 0.05M 0.20M - - -
Total liab - - - 0.20M 0.20M
Total stockholder equity - - - -0.00800M -0.00051M
Deferred long term liab - - - - -
Other current liab 2.51M 6.45M - - -
Common stock 0.95M 0.93M 0.90M 0.90M 0.90M
Capital stock - - - - -
Retained earnings -8.36864M -12.19019M -5.11055M -4.86073M -4.85324M
Other liab - - - - -
Good will - - - 0.19M 0.19M
Other assets - - 0.00000M - -
Cash - - - 0.00181M 0.00243M
Cash and equivalents - - - - -
Total current liabilities 2.88M 6.85M 0.00416M 0.20M -
Current deferred revenue - - - - -
Net debt - - - - -
Short term debt - - - 0.20M -
Short long term debt - - - 0.20M -
Short long term debt total - - - - -
Other stockholder equity - - - - -
Property plant equipment - - 0.00134M 0.00734M 0.01M
Total current assets 0.07M 0.21M 0.05M 0.00181M 0.00243M
Long term investments - - - - -
Net tangible assets -2.81009M -6.64564M 0.04M -0.19374M -0.18625M
Short term investments - - - - -
Net receivables - - - - -
Long term debt - - - - 0.20M
Inventory - - - - -
Accounts payable - - 0.00216M 0.00287M -
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - - -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - -
Deferred long term asset charges - - - - -
Non current assets total - - - - -
Capital lease obligations - - - - -
Long term debt total - - - - -
Breakdown 2023-02-28 2022-02-28 2020-02-29 2019-02-28 2018-02-28
Type yearly yearly yearly yearly yearly
Date 2023-02-28 2022-02-28 2020-02-29 2019-02-28 2018-02-28
Investments - - - - -
Change to liabilities 0.00026M -0.05897M -0.00071M 0.00287M 0.00000M
Total cashflows from investing activities - - 0.24M 0.24M -0.20000M
Net borrowings 0.10M 0.22M 0.00200M 0.00200M 0.20M
Total cash from financing activities 0.00532M 0.28M 0.05M 0.05M 0.20M
Change to operating activities 0.15M -0.08500M -0.08500M -0.08500M -
Net income 3.82M 10.54M -0.24982M -0.00749M -0.00050M
Change in cash 0.01M -0.06759M 0.04M -0.00062M 0.00016M
Begin period cash flow - - - - -
End period cash flow - - - - -
Total cash from operating activities 0.00502M -0.34273M -0.24454M -0.00062M 0.00016M
Issuance of capital stock - - - - -
Depreciation - - 0.00599M 0.00400M 0.00067M
Other cashflows from investing activities - - - - -
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables - - - - -
Sale purchase of stock - - - - -
Other cashflows from financing activities -0.09469M 0.05M 0.05M 0.05M -
Change to netincome -3.99809M -11.01446M -0.00000M -0.00000M -0.00000M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.01M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital - - - - -
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow - - - - -

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to EBITDA (x)
CNNA
Cann American Corp		 0.0006 25.00% 0.003 - - 0.03 0.001 -0.0002
ZTS
Zoetis Inc		 -2.135 2.71% 76.58 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 -0.19 0.62% 30.56 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 - -% 157.12 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 -0.12 0.28% 42.82 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Cann American Corp. is a development stage company dedicated to advancing healthcare solutions through innovative therapies. The company focuses on making healthcare affordable and accessible. By leveraging cutting-edge technology, the company aims to reduce costs and improve the availability of high-quality healthcare services for all patients. The company was formerly known as Canamed4Pets, Inc. and changed its name to Cann American Corp. in December 2019. Cann American Corp. was established in 2004 and is headquartered in Orlando, Florida.

Cann American Corp

121 South Orange Avenue, Orlando, FL, United States, 32801

Key Executives

Name Title Year Born
Mr. Alexander Woods-Leo CEO, Pres, Sec. & Director NA
Mr. Jason R. Tucker CFO, CEO, Secretary, Treasurer & Director 1977
Mr. Michael G. Kramer President, COO and Director 1979

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.